News
- Basilea reports positive preclinical data on oncology drug candidates derazantinib and lisavanbulin at AACR-NCI-EORTC conference
10/30/2019 / 07:15 - GlobeNewswire
-
- Worldwide Cell Based Assay & High Content Screening Market Forecasts to 2024 - Candidate Growth, Immuno-oncology, Genomic Blizzard, Technology Convergence, The Insurance Effect
10/29/2019 / 11:55 - GlobeNewswire
-
- CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results
10/28/2019 / 12:00 - GlobeNewswire
-
- Biological Drugs | Global Market Analysis & Forecast, 2017-2025 - Complexity in the Manufacturing Process is Restraining Growth
10/23/2019 / 12:30 - GlobeNewswire
-
- CV Sciences, Inc. Appoints Dr. Paul Blake to its Board of Directors
10/22/2019 / 14:45 - GlobeNewswire
-
- UK watchdog launches probe into Roche-Spark deal
10/22/2019 / 09:21 - TeleTrader
-
- Hereditary Cancer Testing Markets, 2019-2027 - Growing Demand for Non-invasive Methods of Detection Presents Opportunities
10/16/2019 / 17:08 - GlobeNewswire
-
- Global RNA-Targeted Small Molecules Study, 2019: A Landscape Analysis of Companies, Technologies, Targets, Investors, and Partners from an Industry Perspective
10/16/2019 / 13:51 - GlobeNewswire
-
- Roche sales up 10% to €50.7B in Q3
10/16/2019 / 07:09 - TeleTrader
-
- Ziopharm Oncology Names Drug Development Leader Dr. Chris Bowden to Board of Directors
10/15/2019 / 14:00 - GlobeNewswire
Real-time